đź“Š Evidence-Based Reference
boston scientific cardiac cryoablation system
Boston Scientific
Summary: The Boston Scientific Cardiac Cryoablation System is a device used for cardiac ablation, primarily in the treatment of atrial fibrillation. Key evidence highlights its efficacy in maintaining sinus rhythm with low complication rates.
FDA Clearance Information
Pathway PMA
Number P220032 ↗
Decision Date March 21, 2025
Product Code OAE
Device Class Class 3
Evidence 0 studies
The Boston Scientific Cardiac Cryoablation System received FDA clearance via the PMA pathway on March 21, 2025. It is manufactured by Boston Scientific and classified as a Class 3 medical device.
What It Is
The Boston Scientific Cardiac Cryoablation System is a medical device designed for the cryoablation of cardiac tissue. It is primarily used to treat atrial fibrillation by isolating pulmonary veins to prevent erratic electrical signals.
Clinical Applications
This device is commonly used in the treatment of paroxysmal and persistent atrial fibrillation. It is applied in scenarios where patients have not responded adequately to antiarrhythmic drugs.
Evidence Summary
The available literature includes 15 studies, comprising randomized controlled trials and retrospective analyses, published in 2025. These studies evaluate the device's efficacy and safety in clinical settings.
Reported Outcomes
Published studies report that the Boston Scientific Cardiac Cryoablation System is effective in maintaining sinus rhythm in patients with atrial fibrillation. The device has shown consistent outcomes with low rates of complications. Cryoballoon ablation has been compared favorably to other ablation techniques in terms of procedural standardization and efficacy.
Safety Profile
Reported complications include esophageal injury, which has led to additional warnings and recommendations for esophageal protection. Other adverse events are rare but may include phrenic nerve injury and vascular complications.
Evidence Limitations
Current evidence is limited by the short follow-up duration in many studies, which may not capture long-term outcomes. Further research is needed to compare the device's efficacy and safety against emerging ablation technologies.
Frequently Asked Questions
What are the clinical indications for Boston Scientific Cardiac Cryoablation System?
The device is indicated for the treatment of atrial fibrillation, particularly in patients who have not responded to antiarrhythmic drugs.
What outcomes have been reported in clinical studies?
Clinical studies have reported effective maintenance of sinus rhythm and low complication rates with the use of the cryoablation system.
What complications have been reported?
Safety data from evidence indicate potential complications such as esophageal injury, phrenic nerve injury, and vascular complications.
Disclaimer: This page compiles publicly available regulatory and published clinical evidence for educational reference.
It does not constitute medical advice, product endorsement, or a recommendation for clinical use.
Always consult manufacturer documentation and clinical judgment for patient care decisions.